Skip to main content

and
  1. Article

    Open Access

    Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

    Borderline resectable pancreatic cancers infiltrate into adjacent vascular structures to an extent that makes an R0 resection unlikely when pancreatectomy is performed de novo. In a pilot study, Alliance for C...

    Matthew H. G. Katz, Fang-Shu Ou, Joseph M. Herman, Syed A. Ahmad in BMC Cancer (2017)

  2. No Access

    Article

    Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings

    Bevacizumab is a standard first-line (L1) treatment for metastatic colorectal cancer (mCRC) patients regardless of RAS status. This retrospective study examined treatment patterns and outcomes in a community o...

    Arthur C. Houts, Sarika Ogale, Yousuf Zafar in Journal of Gastrointestinal Cancer (2019)